3-(4-(1H-imidazol-1-ylmethyl)phenyl)-2-propenoic acid,
4-(1-imidazoylmethyl)cinnamic acid,
OKY 046,
OKY-046,
ozagrel,
ozagrel, monohydrochloride,
ozagrel, monohydrochloride, (E)-isomer,
sodium ozagrel,
ozagrel,
82571-53-7,
Ozagrel [INN],
Ozagrelum [Latin],
OKY 046,
OKY-046,
Domenan,
UNII-L256JB984D,
(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid,
CHEMBL11662,
(E)-3-(4-((1H-IMIDAZOL-1-YL)METHYL)PHENYL)ACRYLIC ACID,
C13H12N2O2,
L256JB984D,
Ozagrel (INN),
(E)-p-(Imidazol-1-ylmethyl)cinnamic acid,
2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, (E)-,
KCT-0809,
pulmoza,
Ozagrelum,
3-[4-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]-2E-PROPENOIC ACID,
Cataclot (TN),
4-(1-imidazoylmethyl)cinnamic acid,
Ozagrel,(S),
Prestwick2_000979,
Prestwick3_000979,
3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid,
AC1NR02S,
SCHEMBL4210,
BSPBio_001017,
BPBio1_001119,
GTPL9866,
OKY046,
ZINC5389,
3-(4-(1H-imidazol-1-ylmethyl)phenyl)-2-propenoic acid,
DTXSID6048547,
CHEBI:92359,
CHEBI:134938,
SHZKQBHERIJWAO-AATRIKPKSA-N,
HMS2089O14,
HMS3649M21,
BCP12147,
HY-B0428,
BDBM50017896,
MFCD00868231,
s2496,
AKOS015889403,
AB07569,
AC-2080,
CS-2534,
DB12017,
NCGC00025195-02,
AJ-08246,
AN-14330,
BC209190,
CC-33439,
H981,
SC-22625,
SBI-0207081.P001,
AB0013402,
AB2000601,
BC4304326,
LS-177692,
TL8005457,
AB00514722,
SW197369-5,
3-(4-Imidazol-1-ylmethyl-phenyl)-acrylic acid,
D08327,
(E)-3-(4-((1H-imidazol-1-yl)methyl)phenyl),
AB00514722-10,
AB00514722-12,
AB00514722-13,
AB00514722_14,
AB00514722_15,
4-(1H-Imidazole-1-ylmethyl)benzenepropenoic acid,
571O537,
A840374,
C-13075,
(E)-3-(4-Imidazol-1-ylmethyl-phenyl)-acrylic acid,
I01-1859,
Q-100843,
SR-01000597793-8,
BRD-K19525698-003-01-1,
BRD-K53061490-003-03-0,
(E)-3-[4-(1-imidazolylmethyl)phenyl]-2-propenoic acid,
(2E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid,
(E)-3-[P-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]-2-PROPENO,
(2E)-3-[4-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]ACRYLIC ACID,
2-propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, (2E),
2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, (2E)-,
Ozagrel sodium,
Sodium ozagrel,
Cataclot,
Xanbon,
ozagrel hydrochloride,
OZAGREL HCl,
ACRYLIC ACID,
ozagrel, monohydrochloride,
D0C7AA,
D0T2IH,
Ozagrel hydrochloride hydrate,
CHEMBL542549,
Ozagrel (ophthalmic, eye disorders),
GSK610677,
C13-H12-N2-O2,
ACN-048761,
CID5282440,
ozagrel, monohydrochloride, (E)-isomer,
(E)-4-(imidazol-1-ylmethyl)cinnamic acid,
A4344,
A10688,
C034364,
SR-01000597793,
Ozagrel (ophthalmic, eye disorders), Kissei/ Teika,
Ozagrel(OKY-046) Thromboxane A2 synthetase inhibitor,
(2E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]-2-propenoic acid,
(E)-3-[4-(1H-Imidiazol-1-ylmethyl)phenyl]-2-propenic acid,
(E)-3-(4-(1H-IMIDIAZOL-1-YLMETHYL)PHENYL)-2-PROPENIC ACID,